Lupus-associated antigen La (SSB) (SSB)

The Lupus-associated antigen La, commonly referred to as SSB, is a highly conserved RNA-binding protein that plays a fundamental role in the metabolism of various RNA species (UniProt P05455). It primarily functions as a molecular chaperone for nascent RNA polymerase III transcripts, binding to their 3' oligo(U) tails to protect them from exonucleolytic degradation and facilitate proper folding (Wolin and Cedervall, 2002, PubMed 12105230). Additionally, SSB is involved in the translation of specific cellular and viral mRNAs by interacting with internal ribosome entry sites (IRES), which has led to its investigation as a potential target for antiviral therapies against viruses like hepatitis C (NCBI Gene ID 6741). In the context of human disease, SSB is best known as a major autoantigen in systemic autoimmune disorders, most notably Sjögren's syndrome and systemic lupus erythematosus (StatPearls NBK430904). The detection of anti-La/SSB autoantibodies is a cornerstone of clinical diagnostics, often correlating with early-onset disease and specific complications such as neonatal lupus (PubMed 12105230). While there are currently no FDA-approved drugs that directly modulate SSB function, it remains a significant focus for developing targeted immunotherapies aimed at restoring immune tolerance or blocking the pathogenic effects of autoantibodies.

Other names

SS-BLa proteinSjögren syndrome antigen BLa autoantigenSmall RNA-binding exonuclease protection factor La

None currently approved; experimental strategies focus on inhibiting RNA-binding activity or inducing immune tolerance to the autoantigen.